Genome-wide DNA methylation analysis in Graves' disease

Genomics

Volumn 105, Issue 4, 2015, Pages 204-210

  Cai, Tian tian ^a,b   Muhali, Fatuma said ^a,b   Song, Rong hua ^a,b   Qin, Qiu ^a,b   Wang, Xuan ^a,b   Shi, Liang feng ^b   Jiang, Wen juan ^b   Xiao, Ling ^b   Li, Dan feng ^b   Zhang, Jin an ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b JINSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

DNA methylation; DNMTs; Graves' disease; ICAM1; MBDs; MeDIP chip

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; ICAM1 PROTEIN, HUMAN; MECP2 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA METHYLTRANSFERASE 1 GENE; DNA METHYLTRANSFERASE 3A GENE; DNA METHYLTRANSFERASE 3B GENE; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAVES DISEASE; HUMAN; ICAM1 GENE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MECP2 GENE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; HUMAN GENOME; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; GRAVES DISEASE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; METHYL-CPG-BINDING PROTEIN 2; MIDDLE AGED; RNA, MESSENGER; YOUNG ADULT;

EID: 84924123720     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2015.01.001     Document Type: Article

References (48)

1. Fantz C.R., Dagogo-Jack S., Ladenson J.H., Gronowski A.M. Thyroid function during pregnancy. Clin. Chem. 1999, 45:2250-2258.
2. Swain M., Swain T., Mohanty B.K. Autoimmune thyroid disorders-an update. Indian J. Clin. Biochem. 2005, 20:9-17.
3. Mostoslavsky R., Bergman Y. DNA methylation: regulation of gene expression and role in the immune system. Biochim. Biophys. Acta 1997, 1333:F29-F50.
4. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012, 13:484-492.
5. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
6. Laurent L., Wong E., Li G., Huynh T., Tsirigos A., Ong C.T., et al. Dynamic changes in the human methylome during differentiation. Genome Res. 2010, 20:320-331.
7. Rountree M.R., Bachman K.E., Herman J.G., Baylin S.B. DNA methylation, chromatin inheritance, and cancer. Oncogene 2001, 20:3156-3165.
8. Pradhan S., Bacolla A., Wells R.D., Roberts R.J. Recombinant human DNA (cytosine-5) methyltransferase I. Expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem. 1999, 274:33002-33010.
9. Bird A.P., Wolffe A.P. Methylation-induced repression-belts, braces, and chromatin. Cell 1999, 99:451-454.
10. Leonhardt H., Cardoso M.C. DNA methylation, nuclear structure, gene expression and cancer. J. Cell. Biochem. Suppl. 2000, 79:78-83.
11. Absher D.M., Li X., Waite L.L., Gibson A., Roberts K., Edberg J., et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013, 9:e1003678.
12. Fu L.H., Ma C.L., Cong B., Li S.J., Chen H.Y., Zhang J.G. Hypomethylation of proximal CpG motif of interleukin-10 promoter regulates its expression in human rheumatoid arthritis. Acta Pharmacol. Sin. 2011, 32:1373-1380.
13. Meda F., Folci M., Baccarelli A., Selmi C. The epigenetics of autoimmunity. Cell. Mol. Immunol. 2011, 8:226-236.
14. Brix T.H., Knudsen G.P., Kristiansen M., Kyvik K.O., Orstavik K.H., Hegedüs L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 2005, 90:5949-5953.
15. Simmonds M.J., Kavvoura F.K., Brand O.J., Newby P.R., Jackson L.E., Hargreaves C.E., et al. Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis. J. Clin. Endocrinol. Metab. 2013, 99:E127-E131.
16. Arakawa Y., Watanabe M., Inoue N., Sarumaru M., Hidaka Y., Iwatani Y. Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease. Clin. Exp. Immunol. 2012, 170:194-201.
17. De Santis M., Selmi C. The therapeutic potential of epigenetics in autoimmune diseases. Clin. Rev. Allergy Immunol. 2012, 42:92-101.
18. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10604-10609.
19. Maas K., Chan S., Parker J., Slater A., Moore J., Olsen N., et al. Cutting edge: molecular portrait of human autoimmune disease. J. Immunol. 2002, 169:5-9.
20. Jin Y., Teng W., Ben S., Xiong X., Zhang J., Xu S., et al. Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. J. Clin. Endocrinol. Metab. 2003, 88:1798-1803.
21. Malysheva O., Pierer M., Wagner U., Wahle M., Wagner U., Baerwald C.G. Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitop. Ann. Rheum. Dis. 2008, 67:1759-1764.
22. Togayachi A., Kozono Y., Kuno A., Ohkura T., Sato T., Hirabayashi J., et al. Beta3GnT2 (B3GNT2), a major polylactosamine synthase: analysis of B3GNT2-deficient mice. Methods Enzymol. 2010, 479:185-204.
23. Australo-Anglo-American Spondyloarthritis Consortium (TASC), Reveille J.D., Sims A.M., Danoy P., Evans D.M., Leo P., et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 2010, 42:123-127.
24. Okada Y., Terao C., Ikari K., Kochi Y., Ohmura K., Suzuki A., et al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat. Genet. 2012, 44:511-516.
25. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 2003, 34:395-402.
26. Harney S.M.J., Meisel C., Sims A.M., Woon P.Y., Wordsworth B.P., Brown M.A. Genetic and genomic studies of PADI4 in rheumatoid arthritis. Rheumatology 2005, 44:869-872.
27. Takami N., Osawa K., Miura Y., Komai K., Taniguchi M., Shiraishi M., et al. Hypermethylated promoter region of DR3, the death receptor 3 Gene, in rheumatoid arthritis synovial cells. Arthritis Rheum. 2006, 54:779-787.
28. Altorok N., Coit P., Hughes T., Koelsch K.A., Stone D.U., Rasmussen A., et al. Genome-wide DNA methylation patterns in naive CD4(+) T cells from patients with primary Sjogren's syndrome. Arthritis Rheum. 2014, 66:731-739.
29. González-Amaro R., Sánchez-Madrid F. Cell adhesion molecules: selectins and integrins. Crit. Rev. Immunol. 1999, 19:389-429.
30. Marazuela M., Postigo A.A., Acevedo A., Díaz-González F., Sanchez-Madrid F., de Landázuri M.O. Adhesion molecules from the LFA-1/ICAM-1, 3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. Eur. J. Immunol. 1994, 24:2483-2490.
31. Marazuela M., García-López M.A., Figueroa-Vega N., de la Fuente H., Alvarado-Sánchez B., Monsiváis-Urenda A., et al. Regulatory T cells in human autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 2006, 91:3639-3646.
32. Nowak M., Wielkoszyński T., Kos-Kudła B., Marek B., Karpe J., Kajdaniuk D., et al. The blood concentration of intercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) in patients with active thyroid-associated orbitopathy before and after methylprednisolone treatment. Endokrynol. Pol. 2007, 58:487-491.
33. Pawlowski P., Mysliwiec J., Stasiak-Barmuta A., Bakunowicz-Lazarczyk A., Gorska M. Increased percentage of L-selectin+and ICAM-1+ peripheral blood CD4+/CD8+ T cells in active Graves' ophthalmopathy. Folia Histochem. Cytobiol. 2009, 47:29-33.
34. Nakashima M., Eguchi K., Ida H., Yamashita I., Sakai M., Origuchi T., et al. The expression of adhesion molecules in thyroid glands from patients with Graves' disease. Thyroid 1994, 4:19-25.
35. Kanmaz-Özer M., Doğru-Abbasoğlu S., Vural P., Özderya A., Karadağ B., Uysal M. ICAM1 K469E and E-selectin S128R polymorphisms could predispose to increased autoantibody production and TSH suppression in Graves' disease. Mol. Biol. Rep. 2013, 40:2717-2722.
36. Kim K., Brown E.E., Choi C.B., Alarcón-Riquelme M.E., Kelly J.A., Glenn S.B., et al. Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann. Rheum. Dis. 2012, 71:1809-1814.
37. Navarro-Hernández R.E., Oregon-Romero E., Mercado M.V.D., Rangel-Villalobos H., Palafox-Sánchez C.A., Muñoz-Valle J.F. Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms. Dis. Markers 2009, 26:119-126.
38. Chen H., Kazemier H.G., de Groote M.L., Ruiters M.H., Xu G.L., Rots M.G. Induced DNA demethylation by targeting ten-eleven translocation 2 to the human ICAM-1 promoter. Nucleic Acids Res. 2014, 42:1563-1574.
39. Wiley K.L., Treadwell E., Manigaba K., Word B., Lyn-Cook B.D. Ethnic differences in DNA methyltransferases expression in patients with systemic lupus erythematosus. J. Clin. Immunol. 2013, 33:342-348.
40. Detich N., Theberge J., Szyf M. Promoter-specific activation and demethylation by MBD2/demethylase. J. Biol. Chem. 2002, 277:35791-35794.
41. Balada E., Ordi-Ros J., Serrano-Acedo S., Martinez-Lostao L., Vilardell-Tarrés M. Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J. Leukoc. Biol. 2007, 81:1609-1616.
42. Lei W., Luo Y., Lei W., Luo Y., Yan K., Zhao S., et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 2009, 38:369-374.
43. Liu C.C., Fang T.J., Ou T.T., Wu C.C., Li R.N., Lin Y.C., et al. Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis. Immunol. Lett. 2011, 135:96-99.
44. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 1998, 19:187-191.
45. Kimura H., Shiota K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem. 2003, 278:4806-4812.
46. Zhao M., Gao F., Wu X., Tang J., Lu Q. Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo. Br. J. Dermatol. 2010, 163:736-742.
47. Lu L., Katsaros D., de la Longrais I.A., Sochirca O., Yu H. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 2007, 67:10117-10122.
48. Lo Y.M., Wong I.H., Zhang J., Tein M.S., Ng M.H., Hjelm N.M. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res. 1999, 59:3899-3903.